| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |